ARCHIVES

NCI disclosure of walk-out by Data and Safety Monitoring Board of the National Lung Screening Trial may be harmful, improper, experts say.

This article is from The Cancer Letter archive.

Vol. 30 No. 16 | April 16, 2004

Download PDF Visit The Full Archive

Related Articles

FTE Shortage Hurting Cancer and AIDS Research, Advisors Told; NCI Seeks Major Share Of New Slots

October 14, 1988

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

ASCO, NCCS Call For Oncology Center

September 13, 2002